Elevated Risk of Psychotropic Drug Prescriptions in Adults With Mastocytosis: A Danish Matched Cohort Study.
文献摘要
Background Mastocytosis is a clonal mast cell disorder characterized by chronic mediator-related symptoms and heterogeneous systemic involvement. Neuropsychiatric symptoms are frequently reported, yet population-based evidence on incident depression and/or anxiety remains limited. Objective To examine the mental health burden among patients with mastocytosis. Methods We conducted a population-based matched cohort study using Danish health registers to evaluate incident, pharmacologically treated depression/anxiety among adult patients diagnosed with mastocytosis between 2005 and 2023. Patients were matched 1:5 with individuals from the general Danish population on age, sex, Charlson Comorbidity Index, and educational level. Individuals with psychotropic drug (PD) prescription within 10 years prior to index were excluded. Cumulative risks were estimated using the Aalen-Johansen estimator, and hazard ratios (HRs) were calculated using Cox proportional hazard regression. Results We included 874 patients with mastocytosis and 4370 comparators. Patients had a higher risk of incident PD prescription in the 10 years following diagnosis (p Conclusion Mastocytosis was associated with an increased risk of PD prescriptions, possibly reflecting an increased burden of pharmacologically treated depression and/or anxiety, implying the importance of mental health awareness in clinical management.